US Edition
Weight-Loss Jabs Could Minimise the Symptoms of Asthma
UNITED KINGDOM, JUL 24 – An analysis of over 60,000 UK patients found weight-loss jabs improved asthma control in obese individuals despite only modest average weight loss of 0.9kg, researchers said.
- An international study led by Professor David Price at the University of Aberdeen found that GLP1 agonist drugs reduce asthma symptoms in obese patients.
- Researchers reviewed health data from a patient database encompassing over 60,000 individuals, comparing asthma outcomes between those treated with GLP1 agonists and those who were not.
- The study found GLP1s improved asthma symptoms and increased weight loss, working differently on airway inflammation than traditional steroid treatments, which often fail for obese patients.
- Professor Alan Kaplan noted that GLP1 receptor agonists not only aid weight loss but also contribute to better asthma management in individuals with obesity. Dr Erika Kennington described it as a positive development that asthma control improves with weight loss even when achieved through medication.
- Although findings suggest GLP1 agonists could be a potential treatment for steroid-resistant asthma in obesity, more research is needed to confirm broader effectiveness and mechanisms.
37 Articles
37 Articles
Weight loss jabs could improve asthma symptoms in people with obesity, study finds
New research indicates that medications commonly prescribed for weight reduction might offer significant benefits for asthma sufferers who struggle with obesity, extending beyond simple weight management. The study reveals these drugs could provide relief through mechanisms distinct from conventional steroid treatments.Scientists have discovered that glucagon-like peptide-1 receptor agonists, including medications such as Ozempic, may influence …
GLP1 weight loss injections may reduce asthma symptoms
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and the Observational and Pragmatic Research Institute (OPRI), Singapore.
Bristol Post
Wales OnlineWeight-loss jabs could minimise the symptoms of asthma
They were initially developed as a treatment for people with type 2 diabetes
Chester Standard
Weight-loss jabs such as Mounjaro could help obese people control asthma
Weight-loss jabs such as Mounjaro could also help minimise asthma symptoms in obese people, says a new study, as the NHS rolls out treatment for…
Coverage Details
Bias Distribution
- 77% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
